01.11.2012 Views

DRIVIN G ROWTH - Dr. Reddy's

DRIVIN G ROWTH - Dr. Reddy's

DRIVIN G ROWTH - Dr. Reddy's

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

cash flow statement | YEAR<br />

ENDED MARCH 31<br />

(All amounts in Indian Rupees thousands, except share data)<br />

2002 2001<br />

CASH FLOWS FROM OPERATING ACTIVITIES<br />

Profit before taxation 4,707,728 1,755,483<br />

Adjustments:<br />

Depreciation 474,187 425,145<br />

Amortisation of long-term deposits 22,750 22,750<br />

Income from redemption of mutual fund units (19,420) –<br />

Deferred revenue expenditure written-off 931,354 –<br />

Unrealised foreign exchange gain (127,093) –<br />

Amortisation of marketing development expenditure 11,748 55,525<br />

Deferred R&D expenditure on product development – (192,518)<br />

Provision for decline in the value of long-term investments 217,424 –<br />

Interest income (99,052) (6,357)<br />

Dividend income (4,212) (18,017)<br />

Interest expense 108,985 402,764<br />

Loss on sale of fixed asset 29,029 9,197<br />

Preliminary expenses written-off 500 125<br />

Operating cash flows before working capital changes 6,253,928 2,454,097<br />

(Increase) / decrease in sundry debtors (1,564,370) (320,820)<br />

(Increase) / decrease in inventories (322,064) (294,469)<br />

(Increase) / decrease in loans and advances 15,022 (376,643)<br />

Increase / (decrease) in current liabilities and provisions 620,329 14,544<br />

Cash generated from operations 5,002,845 1,476,709<br />

Income taxes paid (456,970) (272,309)<br />

Net cash provided by operating activities 4,545,875 1,204,400<br />

Cash flows from investing activities<br />

Purchase of fixed assets (1,149,954) (486,007)<br />

Proceeds from sale of fixed assets 26,784 70,913<br />

Purchase of investments (2,411,268) (240,117)<br />

Sale of investments 2,363,680 –<br />

Advances given to subsidiaries and joint ventures (313,119) (32,418)<br />

Repayment of advances given to subsidiaries and joint ventures – 115,125<br />

Interest received 90,208 6,317<br />

Dividend received 4,212 18,017<br />

Net cash used in investing acivities (1,389,457) (548,170)<br />

As per our report attached. For DR. REDDY’S LABORATORIES LIMITED<br />

For BHARAT S RAUT & CO. DR. K ANJI REDDY Chairman<br />

Chartered Accountants G V PRASAD Executive Vice Chairman & CEO<br />

K SATISH REDDY Managing Director & COO<br />

PRADIP KANAKIA DR. OMKAR GOSWAMI Director<br />

Partner V S VASUDEVAN Chief Financial Officer<br />

SANTOSH KUMAR NAIR Company Secretary<br />

For A RAMACHANDRA RAO & CO.<br />

Chartered Accountants<br />

A RAMACHANDRA RAO<br />

Partner<br />

Hyderabad<br />

June 4, 2002<br />

DR. REDDY’S LABORATORIES LTD. | FINANCIALS | ANNUAL REPORT 2001-2002<br />

133

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!